Section 32 is a venture capital fund investing at the frontiers of technology, healthcare and the life sciences. Founded by Bill Maris.

Section 32 focus areas include biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence.

The firm’s goal is to improve the human condition by accelerating the discovery, development, adoption and distribution of important technologies and life saving medicines.